Actavis Llc. Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Actavis Llc. Pharmaceutical Import Records from India — 3 Products, $42.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Actavis Llc. — Pharmaceutical Importer Profile (2026) | 3 Products, $42.0M Trade | TransData Nexus

Actavis Llc.

Pharmaceutical Importer · United States · CNS & Psychiatric Focus · $42.0M Total Trade · DGFT Verified

Actavis Llc. is a pharmaceutical importer based in United States with a total trade value of $42.0M across 3 products in 2 therapeutic categories. Based on 939 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Actavis Llc. sources from 1 verified Indian supplier, with Watson Pharma Private Limited accounting for 100.0% of imports.

Actavis Llc. — Import Portfolio & Supplier Network

Actavis Llc. import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Actavis Llc.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Watson Pharma Private Limited	$36.4M	854	100.0%

Actavis Llc. sources from 1 verified Indian supplier across 405 distinct formulations. The sourcing is highly concentrated — Watson Pharma Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Actavis Llc. Import?

Formulation	Value	Ships
Gabapentin capsules USP 300MG (batch	$7.4M	174
Gabapentin capsules USP 300 MG (batch	$5.0M	118
Gabapentin capsules USP 300 MG (batch	$2.0M	50
Gabapentin capsules USP 100MG (batch	$750.0K	15
Gabapentin capsules USP 400 MG (batch	$662.0K	16
Gabapentin capsules USP 400 MG (batch	$634.9K	16
Gabapentin capsules USP 100 MG (batch	$600.0K	12
Gabapentin capsules USP 100 MG (batch	$500.0K	10
Gabapentin capsules USP 300 MG (batch	$381.1K	9
Gabapentin capsules USP 300 MG ( batch	$290.9K	7
Gabapentin capsules USP 400 MG	$201.1K	5
Gabapentin capsules USP 300 MG	$166.5K	4
Sulindac tablets USP 150 MG (batch	$150.0K	3
Sulindac tablets USP 200 MG (batch	$150.0K	3
Gabapentin capsules USP 400 MG ( batch	$120.5K	3

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Gabapentin	CNS & Psychiatric	$40.4M	902	3.7%	4
2	Alprazolam	CNS & Psychiatric	$991.7K	26	4.6%	6
3	Prednisone	Respiratory	$550.0K	11	2.0%	5

Actavis Llc. imports 3 pharmaceutical products across 2 categories into United States totaling $42.0M.

Actavis Llc. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Actavis LLC is a pharmaceutical importer and buyer based in the United States, specializing in the acquisition of finished pharmaceutical formulations from international suppliers. The company operates as a key player in the U.S. pharmaceutical distribution network, focusing on sourcing and importing generic medications to meet domestic market demands. Actavis LLC is headquartered in Edison, New Jersey, and maintains a significant presence in the pharmaceutical industry through its strategic sourcing and distribution activities.

2Distribution Network

Actavis LLC's distribution network is centered in Edison, New Jersey, serving as a pivotal hub for the company's import and distribution operations. The company's logistics capabilities are designed to efficiently handle a substantial volume of pharmaceutical imports, ensuring timely delivery to various regions across the United States. While specific warehouse locations and geographic coverage details are not publicly disclosed, Actavis LLC's strategic positioning in New Jersey facilitates access to major U.S. markets and ports, optimizing its distribution efficiency.

3Industry Role

In the United States pharmaceutical supply chain, Actavis LLC functions primarily as a pharmaceutical importer and buyer. The company focuses on sourcing finished pharmaceutical formulations from international suppliers, particularly from India, to meet the domestic demand for generic medications. By importing a diverse range of generic drugs, Actavis LLC plays a crucial role in enhancing the availability and affordability of pharmaceutical products within the U.S. market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Actavis Llc.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Actavis LLC demonstrates a high degree of supplier concentration, with a significant majority of its pharmaceutical imports sourced from a single supplier: Watson Pharma Private Limited. This sourcing strategy indicates a strong, long-term partnership between Actavis LLC and Watson Pharma, suggesting a stable and reliable supply chain. However, such dependency also presents potential risks, including vulnerability to supply disruptions or changes in supplier dynamics. The consistent volume of shipments over the years reflects a well-established and dependable relationship, yet it also underscores the importance of maintaining this partnership to ensure uninterrupted access to critical pharmaceutical products.

2Supply Chain Resilience

The resilience of Actavis LLC's supply chain is closely tied to its exclusive reliance on Watson Pharma Private Limited for pharmaceutical imports. This singular sourcing approach may limit the company's ability to mitigate risks associated with supply chain disruptions, such as production delays or regulatory challenges faced by the supplier. The lack of backup suppliers and limited formulation diversity further constrains the company's flexibility in responding to unforeseen supply chain challenges. Additionally, the exposure to specific shipping routes and potential regulatory compliance issues with the sole supplier could impact the overall stability and resilience of Actavis LLC's supply chain.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation, approval, and marketing of pharmaceutical products. The FDA enforces stringent regulations to ensure the safety, efficacy, and quality of drugs entering the U.S. market. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which outlines the requirements for drug approval and importation. The FDA's New Drug Application (NDA) and Abbreviated New Drug Application (ANDA) processes are central to the marketing authorization pathway for pharmaceutical products, including generics sourced from countries like India.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are governed by the FDA, which mandates that all imported drugs comply with U.S. regulations and standards. Manufacturers and suppliers must obtain FDA approval for their products, demonstrating adherence to Good Manufacturing Practices (GMP). The FDA recognizes GMP certifications from reputable international bodies, including the European Union's EU GMP, the World Health Organization's WHO GMP, and the Pharmaceutical Inspection Co-operation Scheme's PIC/S. These certifications are essential for ensuring that imported pharmaceutical products meet the necessary quality standards for distribution in the U.S. market.

Actavis Llc. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Actavis LLC's focus on importing generic medications in the Central Nervous System (CNS) and Psychiatric therapeutic category aligns with the significant demand for affordable treatments in these areas. The company's importation of Gabapentin, Alprazolam, and Prednisone addresses prevalent conditions such as neuropathic pain, anxiety disorders, and inflammatory diseases. By sourcing these products, Actavis LLC contributes to enhancing patient access to essential medications, thereby supporting public health objectives and meeting market needs.

2Sourcing Profile

Actavis LLC's sourcing strategy emphasizes the procurement of generic drugs, particularly those in the CNS and Psychiatric therapeutic categories. The company's preference for finished pharmaceutical formulations over raw Active Pharmaceutical Ingredients (APIs) indicates a focus on ready-to-market products that can be swiftly distributed within the U.S. market. India's robust pharmaceutical manufacturing sector, known for its compliance with international GMP standards, positions it as a key supplier for Actavis LLC's procurement needs.

3Market Positioning

Seller's Guide — How to Become a Supplier to Actavis Llc.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Actavis LLC, particularly in the CNS and Psychiatric therapeutic categories. Actavis LLC's current sourcing pattern, heavily reliant on a single supplier, presents an opportunity for diversification, which could enhance supply chain resilience and potentially lead to more competitive pricing. Indian exporters can explore this opportunity by ensuring compliance with FDA regulations, obtaining necessary certifications, and establishing reliable supply capabilities to meet Actavis LLC's quality and logistical requirements.

2Requirements & Qualifications

Indian exporters aiming to supply Actavis LLC and the U.S. market must adhere to FDA regulations, including obtaining necessary import licenses and ensuring compliance with GMP standards recognized by the FDA. Products must undergo batch testing and stability studies to meet U.S. quality standards. Labeling must be in English, providing comprehensive product information. Additionally, exporters must implement serialization to comply with U.S. regulations aimed at preventing counterfeit drugs.

3How to Approach

Frequently Asked Questions — Actavis Llc.

What products does Actavis Llc. import from India?

Actavis Llc. imports 3 pharmaceutical products across 2 categories. Top imports: Gabapentin ($40.4M), Alprazolam ($991.7K), Prednisone ($550.0K).

Who supplies pharmaceuticals to Actavis Llc. from India?

Actavis Llc. sources from 1 verified Indian suppliers. The primary supplier is Watson Pharma Private Limited (100.0% of imports, $36.4M).

What is Actavis Llc.'s total pharmaceutical import value?

Actavis Llc.'s total pharmaceutical import value from India is $42.0M, based on 939 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Actavis Llc. focus on?

Actavis Llc. imports across 2 categories. The largest: CNS & Psychiatric (98.7%), Respiratory (1.3%).

Get Full Actavis Llc. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.